X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17069) 17069
Book Review (3433) 3433
Publication (774) 774
Book Chapter (110) 110
Book / eBook (18) 18
Dissertation (13) 13
Conference Proceeding (10) 10
Magazine Article (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14491) 14491
index medicus (14294) 14294
percutaneous coronary intervention (10715) 10715
male (9852) 9852
female (9315) 9315
cardiac & cardiovascular systems (9238) 9238
middle aged (8027) 8027
aged (7959) 7959
treatment outcome (7235) 7235
risk factors (5067) 5067
percutaneous coronary intervention - adverse effects (4203) 4203
time factors (4091) 4091
stents (3285) 3285
mortality (3075) 3075
transluminal angioplasty (2894) 2894
cardiovascular (2840) 2840
angioplasty (2792) 2792
cardiology (2763) 2763
coronary angiography (2706) 2706
drug-eluting stents (2530) 2530
retrospective studies (2450) 2450
prospective studies (2296) 2296
abridged index medicus (2295) 2295
cardiac patients (2272) 2272
aged, 80 and over (2104) 2104
care and treatment (2095) 2095
heart attacks (2067) 2067
risk assessment (2028) 2028
coronary artery disease - therapy (1935) 1935
follow-up studies (1910) 1910
percutaneous coronary intervention - methods (1892) 1892
myocardial infarction - therapy (1866) 1866
outcomes (1856) 1856
myocardial infarction (1851) 1851
stent (1795) 1795
analysis (1767) 1767
coronary heart disease (1743) 1743
thrombosis (1677) 1677
percutaneous coronary intervention - instrumentation (1667) 1667
peripheral vascular disease (1634) 1634
clopidogrel (1603) 1603
acute myocardial-infarction (1582) 1582
platelet aggregation inhibitors - therapeutic use (1578) 1578
intervention (1574) 1574
surgery (1539) 1539
angioplasty, balloon, coronary - adverse effects (1528) 1528
heart attack (1514) 1514
adult (1501) 1501
registries (1443) 1443
coronary artery disease (1433) 1433
percutaneous coronary intervention - mortality (1433) 1433
prognosis (1418) 1418
predictive value of tests (1381) 1381
myocardial-infarction (1369) 1369
cardiovascular disease (1354) 1354
prosthesis design (1352) 1352
artery-disease (1337) 1337
ticlopidine - analogs & derivatives (1326) 1326
medicine & public health (1318) 1318
myocardial infarction - mortality (1295) 1295
trial (1281) 1281
patients (1263) 1263
risk (1261) 1261
implantation (1256) 1256
kaplan-meier estimate (1222) 1222
angiography (1200) 1200
impact (1171) 1171
incidence (1139) 1139
coronary vessels (1135) 1135
multivariate analysis (1104) 1104
myocardial infarction - etiology (1098) 1098
revascularization (1088) 1088
platelet aggregation inhibitors - adverse effects (1080) 1080
cardiology and cardiovascular medicine (1076) 1076
electrocardiography (1071) 1071
coronary artery disease - surgery (1065) 1065
acute coronary syndromes (1064) 1064
medicine, general & internal (1064) 1064
cardiovascular diseases (1042) 1042
chi-square distribution (1030) 1030
health aspects (1026) 1026
platelet aggregation inhibitors - administration & dosage (1021) 1021
metaanalysis (1015) 1015
coronary artery disease - mortality (1003) 1003
disease (996) 996
patient outcomes (981) 981
proportional hazards models (981) 981
odds ratio (946) 946
therapy (941) 941
aspirin (940) 940
coronary artery bypass (934) 934
acute coronary syndrome (911) 911
logistic models (905) 905
management (877) 877
clinical-outcomes (864) 864
coronary artery disease - diagnostic imaging (864) 864
usage (864) 864
myocardial infarction - diagnosis (863) 863
elevation myocardial-infarction (840) 840
research (840) 840
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16916) 16916
German (60) 60
Russian (49) 49
Chinese (42) 42
Spanish (31) 31
French (19) 19
Polish (19) 19
Portuguese (19) 19
Italian (14) 14
Turkish (12) 12
Dutch (9) 9
Japanese (8) 8
Korean (4) 4
Hungarian (2) 2
Swedish (2) 2
Danish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2013, Volume 33, Issue 9, pp. 2252 - 2260
OBJECTIVE—Experimental evidence suggests that exenatide, a glucagon-like peptide 1 receptor analogue, has significant cardiovascular protective effects in... 
magnetic resonance imaging | percutaneous coronary intervention | reperfusion injury | myocardial infarction | exenatide | SURVIVAL | RAT | HEART-FAILURE | SIZE | ISCHEMIA | GLUCAGON-LIKE PEPTIDE-1 | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | HEMATOLOGY | STRAIN | OCCLUSION | Myocardial Infarction - blood | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Myocardial Contraction - drug effects | Male | Peptides - administration & dosage | Troponin I - blood | Cardiotonic Agents - therapeutic use | Myocardial Infarction - therapy | Hypoglycemic Agents - administration & dosage | Time Factors | Cardiotonic Agents - adverse effects | Injections, Subcutaneous | Myocardial Infarction - pathology | Echocardiography, Doppler | Venoms - administration & dosage | Female | Myocardial Infarction - physiopathology | Republic of Korea | Hypoglycemic Agents - therapeutic use | Drug Administration Schedule | Venoms - adverse effects | Ventricular Function, Left - drug effects | Proportional Hazards Models | Stroke Volume - drug effects | Myocardium - pathology | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Magnetic Resonance Imaging | Myocardium - enzymology | Cardiotonic Agents - administration & dosage | Venoms - therapeutic use | Creatine Kinase, MB Form - blood | Aged | Hypoglycemic Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Peptides - adverse effects | Peptides - therapeutic use | Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 12/2016, Volume 182, pp. 1 - 8
Dual antiplatelet therapy (DAPT) is a fundamental treatment that optimizes clinical outcomes after percutaneous coronary intervention, especially in patients... 
DEFINITIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | METAANALYSIS | MYOCARDIAL-INFARCTION | EFFICACY | IMPLANTATION | BARE-METAL STENTS | DRUG-ELUTING STENTS | CLINICAL-OUTCOMES | Humans | Immunosuppressive Agents - therapeutic use | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Adult | Everolimus - therapeutic use | Female | Republic of Korea | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Treatment Outcome | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Hemorrhage - chemically induced | Drug Monitoring | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Medicine, Experimental | Medical research | Care and treatment | Coronary heart disease | Cardiac patients | Blood transfusions | Anticoagulants | Thoracic surgery | Life expectancy | Heart attacks | Enrollments | Comorbidity | Mortality | Cardiovascular disease | Angina pectoris | Clinical outcomes | Studies | Contrast agents | Hypotheses | Surgery | Coronary vessels | Acute coronary syndromes | Health risk assessment | Cardiology | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 9, pp. 1036 - 1045
Abstract Background The incidence, predictors, and prognostic impact of post-discharge bleeding (PDB) after percutaneous coronary intervention (PCI) with... 
Cardiovascular | Internal Medicine | late bleeding | mortality | platelet reactivity | HARMONIZING OUTCOMES | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | RANDOMIZED-TRIALS | MYOCARDIAL-INFARCTION TRIALS | NETWORK METAANALYSIS | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | TREATMENT PLATELET REACTIVITY | ELUTING STENT IMPLANTATION | DURATION | Multivariate Analysis | Predictive Value of Tests | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Patient Discharge | Drug-Eluting Stents - adverse effects | Dose-Response Relationship, Drug | Percutaneous Coronary Intervention - methods | Adult | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Postoperative Hemorrhage - mortality | Drug Administration Schedule | Postoperative Care - adverse effects | Risk Assessment | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Care - methods | Radiography | Postoperative Hemorrhage - etiology | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Survival Analysis | Aged | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Sects | Medical colleges | Heart attacks | Cardiology | Stents | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 23, pp. 2223 - 2235
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 10/2014, Volume 130, Issue 16, pp. 1392 - 1406
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9892, pp. 614 - 623
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 791 - 801